A
Ataraxis AI
AI-driven diagnostic tests enhancing precision medicine with rapid, personalized cancer prognostics
About Ataraxis AI
Ataraxis AI is a precision medicine company focused on revolutionizing cancer diagnostics through advanced AI technology. With a recent emergence from stealth mode and backed by $4 million in seed funding, Ataraxis AI has introduced its first product, Ataraxis Breast, an AI-native prognostic test for breast cancer. This test is designed to significantly improve the prediction of patient outcomes, allowing for more precise and personalized treatment plans. Operating in the healthcare sector, particularly in oncology, Ataraxis AI serves physicians and healthcare providers by offering rapid diagnostic results within one business day. The company's business model revolves around providing these AI-powered diagnostic tests, which are accessible through a physician portal or delivered directly to clinicians. By leveraging AI, Ataraxis AI aims to set a new standard in molecular diagnostics, traditionally the benchmark for personalized treatment selection.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2023
- Headquarters
- New York City, United States
- Employees
- 43
- Open positions
- 17
- Dealroom signal
- 89.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Core AI, Precision Medicine, Spinout, Biotech and Pharma, AI Drug Discovery, Techbio, AI Applications, DT and LS, out of stealth
- Technology
- Artificial Intelligence
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2026 | $20M | $82M | Bertelsmann · Obvious Ventures · Founders Fund · Giant Ventures | ↗ |
| SERIES A✓Equity / VC | Jan 2025 | $20M | $82M | Founders Fund · Floating Point · Thiel Bio · Giant Ventures | ↗ |
Growth signals
Latest recorded traffic for Ataraxis AI is 4.8K monthly website visits, down 12.7% over the last three months. Ataraxis AI's team grew 4200% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Obvious Ventures
Giant Ventures
Series A5 investors entered at this stage
AIX Ventures
Founders Fund
Floating Point
Thiel Bio
Bertelsmann
Other known investors2 additional known investors
New York University
Endless Frontier Labs
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ataraxis AI on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ataraxis AI’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.